Please assess the completion status of the following clinical trial:

Trial Title: Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Individual is 2 - 80 years of age at time of enrollment~2. A clinical diagnosis of type 1 or 2 diabetes for a minimum of 6 months duration as determined via medical record or source documentation by an individual qualified to make a medical diagnosis~3. Adequate venous access as assessed by investigator or appropriate staff~4. Subjects participating in the high and low glucose challenges must have an insulin carbohydrate ratio(s) and insulin sensitivity ratio. Subjects without ratios may participate under observation only~Exclusion Criteria:~1. Subject will not tolerate tape adhesive in the area of Guardian™ Sensor (3) placement as assessed by a qualified individual.~2. Subject has any unresolved adverse skin condition in the area of sensor or device placement (e.g., psoriasis, rash, Staphylococcus infection)~3. Subject is actively participating in an investigational study (drug or device) wherein they have received treatment from an investigational study (drug or device) in the last 2 weeks~4. Subject is female and has a positive pregnancy screening test~5. Female of child bearing age and who is sexually active should be excluded if she is not using a form of contraception deemed reliable by investigator~6. Subject is female and plans to become pregnant during the course of the study~7. Subject has had a hypoglycemic seizure within the past 6 months prior to enrollment~8. Subject has had hypoglycemia resulting in loss of consciousness within the past 6 months prior to enrollment.~9. Subject has had an episode of diabetic ketoacidosis (DKA) within the past 6 months prior to enrollment.~10. Subject has a history of a seizure disorder~11. Subject has central nervous system or cardiac disorder resulting in syncope~12. Subject has a history of myocardial infarction, unstable angina, coronary artery bypass surgery, coronary artery stenting, transient ischemic attack (TIA), cerebrovascular accident (CVA), angina, congestive heart failure, ventricular rhythm disturbances or thromboembolic disease~13. Subject has a hematocrit (Hct) lower than the normal reference range (please note that patients may use prior blood draw from routine care as long as done within 6 months of screening and report of lab placed with subject source documents)~14. Subject has a history of adrenal insufficiency~15. Subject is a member of the research staff involved with the study.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Subjects with diabetes wearing Guardian™ Sensor (3) (Type: OTHER): Subjects wear Guardian™ Sensor (3) and Guardian™ Connect Transmitter over 7 days and participate in FSTs. Zero calibration sensor algorithm applied to raw sensor data.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete